Insider Stock Trading History of Shah Sujal


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Shah Sujal since year 2005. The trader's CIK number is 1588861. At the time of this reporting, Shah Sujal is the Interim President & CEO of Cymabay Therapeutics, Inc. . (stock ticker symbol NONE). See this page for all insider trading activities at Cymabay Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Shah Sujal since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-07-20 CBAY Cymabay Therapeutics, Inc. Buy 10,000 7.31 73,140
2016-04-05 CBAY Cymabay Therapeutics, Inc. Buy 33,000 1.39 45,870
2016-04-04 CBAY Cymabay Therapeutics, Inc. Buy 22,000 1.39 30,579
2015-05-18 CBAY Cymabay Therapeutics, Inc. Buy 10,000 3.40 34,000
2014-09-16 NONE Cymabay Therapeutics, Inc. Buy 10,000 7.44 74,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shah Sujal (Interim President & CEO of Cymabay Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.